Substitution model of sequence evolution for the human immunodeficiency virus type 1 subtype B gp120 gene over the C2-V5 region

被引:15
|
作者
Anderson, JP [1 ]
Rodrigo, AG
Learn, GH
Wang, Y
Weinstock, H
Kalish, ML
Robbins, KE
Hood, L
Mullins, JI
机构
[1] Univ Washington, Hlth Sci Ctr, Dept Mol Biotechnol, Seattle, WA 98195 USA
[2] Univ Washington, Hlth Sci Ctr, Dept Microbiol, Seattle, WA 98195 USA
[3] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
关键词
HIV-1; env; nucleotide substitution rates; rate heterogeneity; maximum likelihood; evolutionary model; simulations;
D O I
10.1007/s002390010192
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phylogenetic analyses frequently rely on models of sequence evolution that detail nucleotide substitution rates, nucleotide frequencies, and site-to-site rate heterogeneity. These models can influence hypothesis testing and can affect the accuracy of phylogenetic inferences. Maximum likelihood methods of simultaneously constructing phylogenetic tree topologies and estimating model parameters are computationally intensive, and are not feasible for sample sizes of 25 or greater using personal computers. Techniques that initially construct a tree topology and then use this non-maximized topology to estimate ML substitution rates, however, can quickly arrive at a model of sequence evolution. The accuracy of this two-step estimation technique was tested using simulated data sets with known model parameters. The results showed that for a star-like topology, as is often seen in human immunodeficiency virus type 1 (HIV-1) subtype B sequences, a random starting topology could produce nucleotide substitution rates that were not statistically different than the true rates. Samples were isolated from 100 HIV-1 subtype B infected individuals from the United States and a 620 nt region of the env gene was sequenced for each sample. The sequence data were used to obtain a substitution model of sequence evolution specific for HIV-1 subtype B env by estimating nucleotide substitution rates and the site-to-site heterogeneity in 100 individuals from the United States. The method of estimating the model should provide users of large data sets with a way to quickly compute a model of sequence evolution, while the nucleotide substitution model we identified should prove useful in the phylogenetic analysis of HIV-1 subtype B env sequences.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [1] Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
    Stanfield, RL
    Ghiara, JB
    Saphire, EO
    Profy, AT
    Wilson, IA
    VIROLOGY, 2003, 315 (01) : 159 - 173
  • [2] Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120
    Kirchherr, Jennifer L.
    Hamilton, Jennifer
    Lu, Xiaozhi
    Gnanakaran, S.
    Muldoon, Mark
    Daniels, Marcus
    Kasongo, Webster
    Chalwe, Victor
    Mulenga, Chanda
    Mwananyanda, Lawrence
    Musonda, Rosemary M.
    Yuan, Xing
    Montefiori, David C.
    Korber, Bette T.
    Haynes, Barton F.
    Gao, Feng
    VIROLOGY, 2011, 409 (02) : 163 - 174
  • [3] UCLA1, a Synthetic Derivative of a gp120 RNA Aptamer, Inhibits Entry of Human Immunodeficiency Virus Type 1 Subtype C
    Mufhandu, Hazel T.
    Gray, Elin S.
    Madiga, Maphuti C.
    Tumba, Nancy
    Alexandre, Kabamba B.
    Khoza, Thandeka
    Wibmer, Constantinos Kurt
    Moore, Penny L.
    Morris, Lynn
    Khati, Makobetsa
    JOURNAL OF VIROLOGY, 2012, 86 (09) : 4989 - 4999
  • [4] Human immunodeficiency virus type 1 clade B and C gp120 differentially induce neurotoxin arachidonic acid in human astrocytes: implications for neuroAIDS
    Samikkannu, Thangavel
    Agudelo, Marisela
    Gandhi, Nimisha
    Reddy, Pichili V. B.
    Saiyed, Zainulabedin M.
    Nwankwo, Donald
    Nair, Madhavan P. N.
    JOURNAL OF NEUROVIROLOGY, 2011, 17 (03) : 230 - 238
  • [5] Immunoinformatics Study of gp120 of Human Immunodeficiency Virus Type 1 Subtype CRF35_AD Isolated from Iranian Patients
    Keyvani, Hossein
    Ahmadi, Nayeb Ali
    Ranjbar, Mohammad Mehdi
    Kachooei, Saeid Ataei
    Ghorban, Khodayar
    Dadmanesh, Maryam
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2016, 11 (04):
  • [6] Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41
    Anastasopoulou, Cleo G.
    Ketas, Thomas J.
    Depetris, Rafael S.
    Thomas, Antonia M.
    Klasse, Per Johan
    Moore, John P.
    VIROLOGY, 2011, 413 (01) : 47 - 59
  • [7] Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans
    Rao, Mangala
    Onkar, Sayali
    Peachman, Kristina K.
    White, Yohann
    Trinh, Hung V.
    Jobe, Ousman
    Zhou, Yingjun
    Dawson, Peter
    Eller, Michael A.
    Matyas, Gary R.
    Alving, Carl R.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (10) : 1541 - 1550
  • [8] Shaping T Cell - B Cell Collaboration in the Response to Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 by Peptide Priming
    Steede, N. Kalaya
    Rust, Blake J.
    Hossain, Mohammad M.
    Freytag, Lucy C.
    Robinson, James E.
    Landry, Samuel J.
    PLOS ONE, 2013, 8 (06):
  • [9] Elicitation of neutralizing antibodies by intranasal administration of recombinant vesicular stomatitis virus expressing human immunodeficiency virus type 1 gp120
    Jiang, PF
    Liu, YX
    Yin, XL
    Yuan, F
    Nie, YC
    Luo, M
    Zheng, AH
    Du, LY
    Ding, MX
    Deng, HK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 339 (02) : 526 - 532
  • [10] Detection of IgA-binding sites on human immunodeficiency virus type-1 envelope glycoproteins, Gp120 and Gp41
    Matsuda, S
    Noda, M
    MICROBIOLOGY AND IMMUNOLOGY, 2000, 44 (11) : 923 - 929